-
1
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
2
-
-
0031740494
-
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee
-
Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-48.
-
(1998)
Am J Surg Pathol
, vol.22
, pp. 1435-1448
-
-
Epstein, J.I.1
Amin, M.B.2
Reuter, V.R.3
Mostofi, F.K.4
-
3
-
-
0023867072
-
Natural history and treatment of low and high risk superficial bladder tumors
-
Rubben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W, Giani G. Natural history and treatment of low and high risk superficial bladder tumors. J Urol 1988; 139: 283-5.
-
(1988)
J Urol
, vol.139
, pp. 283-285
-
-
Rubben, H.1
Lutzeyer, W.2
Fischer, N.3
Deutz, F.4
Lagrange, W.5
Giani, G.6
-
4
-
-
0033694919
-
Multimodality therapy for the treatment of muscle-invasive bladder cancer
-
Thurman SA, DeWeese TL. Multimodality therapy for the treatment of muscle-invasive bladder cancer. Semin Urol Oncol 2000; 18: 313-22.
-
(2000)
Semin Urol Oncol
, vol.18
, pp. 313-322
-
-
Thurman, S.A.1
DeWeese, T.L.2
-
5
-
-
0017102047
-
Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ
-
Althausen AF, Prout GR Jr, Daly JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976; 116: 575-80.
-
(1976)
J Urol
, vol.116
, pp. 575-580
-
-
Althausen, A.F.1
Prout Jr, G.R.2
Daly, J.J.3
-
6
-
-
0033992352
-
Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome
-
discussion 1-2.
-
Herr HW. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000; 163: 60-1; discussion 1-2.
-
(2000)
J Urol
, vol.163
, pp. 60-61
-
-
Herr, H.W.1
-
7
-
-
30044446209
-
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers
-
Habuchi T, Marberger M, Droller MJ et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 2005; 66: 64-74.
-
(2005)
Urology
, vol.66
, pp. 64-74
-
-
Habuchi, T.1
Marberger, M.2
Droller, M.J.3
-
8
-
-
0027759847
-
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer
-
Esrig D, Spruck CH III, Nichols PW et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 1993; 143: 1389-97.
-
(1993)
Am J Pathol
, vol.143
, pp. 1389-1397
-
-
Esrig, D.1
Spruck III, C.H.2
Nichols, P.W.3
-
9
-
-
77953815362
-
p53 immunohistochemistry in bladder cancer-a new approach to an old question
-
Goebell PJ, Groshen SG, Schmitz-Drager BJ. p53 immunohistochemistry in bladder cancer-a new approach to an old question. Urol Oncol 2010; 28: 377-88.
-
(2010)
Urol Oncol
, vol.28
, pp. 377-388
-
-
Goebell, P.J.1
Groshen, S.G.2
Schmitz-Drager, B.J.3
-
10
-
-
0035805051
-
Decreasing of p27(Kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer
-
Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI. Decreasing of p27(Kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Br J Cancer 2001; 84: 1242-51.
-
(2001)
Br J Cancer
, vol.84
, pp. 1242-1251
-
-
Kamai, T.1
Takagi, K.2
Asami, H.3
Ito, Y.4
Oshima, H.5
Yoshida, K.I.6
-
11
-
-
0033932176
-
Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1
-
Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Hum Pathol 2000; 31: 751-60.
-
(2000)
Hum Pathol
, vol.31
, pp. 751-760
-
-
Korkolopoulou, P.1
Christodoulou, P.2
Konstantinidou, A.E.3
Thomas-Tsagli, E.4
Kapralos, P.5
Davaris, P.6
-
12
-
-
62549084737
-
Differential plasma glycoproteome of p19 skin cancer mouse model using the corra label-free LC-MS proteomics platform
-
Letarte S, Brusniak MY, Campbell D et al. Differential plasma glycoproteome of p19 skin cancer mouse model using the corra label-free LC-MS proteomics platform. Clin Proteomics 2008; 4: 105.
-
(2008)
Clin Proteomics
, vol.4
, pp. 105
-
-
Letarte, S.1
Brusniak, M.Y.2
Campbell, D.3
-
13
-
-
71449102739
-
Bikunin loss in urine as useful marker for bladder carcinoma
-
Tsui KH, Tang P, Lin CY, Chang PL, Chang CH, Yung BY. Bikunin loss in urine as useful marker for bladder carcinoma. J Urol 2010; 183: 339-44.
-
(2010)
J Urol
, vol.183
, pp. 339-344
-
-
Tsui, K.H.1
Tang, P.2
Lin, C.Y.3
Chang, P.L.4
Chang, C.H.5
Yung, B.Y.6
-
14
-
-
30044441045
-
Bladder cancer: epidemiology, staging and grading, and diagnosis
-
Kirkali Z, Chan T, Manoharan M et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66: 4-34.
-
(2005)
Urology
, vol.66
, pp. 4-34
-
-
Kirkali, Z.1
Chan, T.2
Manoharan, M.3
-
15
-
-
46749150111
-
Comparative proteomics analysis of vascular smooth muscle cells incubated with S- and R-enantiomers of atenolol using iTRAQ-coupled two-dimensional LC-MS/MS
-
Sui J, Zhang J, Tan TL, Ching CB, Chen WN. Comparative proteomics analysis of vascular smooth muscle cells incubated with S- and R-enantiomers of atenolol using iTRAQ-coupled two-dimensional LC-MS/MS. Mol Cell Proteomics 2008; 7: 1007-18.
-
(2008)
Mol Cell Proteomics
, vol.7
, pp. 1007-1018
-
-
Sui, J.1
Zhang, J.2
Tan, T.L.3
Ching, C.B.4
Chen, W.N.5
-
16
-
-
70349268329
-
Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guerin
-
Palou J, Algaba F, Vera I, Rodriguez O, Villavicencio H, Sanchez-Carbayo M. Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guerin. Eur Urol 2009; 56: 829-36.
-
(2009)
Eur Urol
, vol.56
, pp. 829-836
-
-
Palou, J.1
Algaba, F.2
Vera, I.3
Rodriguez, O.4
Villavicencio, H.5
Sanchez-Carbayo, M.6
-
17
-
-
39849105855
-
Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples
-
Tsui KH, Juang HH, Lee TH, Chang PL, Chen CL, Yung BY. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples. Acta Pharmacol Sin 2008; 29: 364-70.
-
(2008)
Acta Pharmacol Sin
, vol.29
, pp. 364-370
-
-
Tsui, K.H.1
Juang, H.H.2
Lee, T.H.3
Chang, P.L.4
Chen, C.L.5
Yung, B.Y.6
-
18
-
-
31944447547
-
Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer
-
Tzai TS, Tsai YS, Shiau AL, Wu CL, Shieh GS, Tsai HT. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer. Urology 2006; 67: 294-9.
-
(2006)
Urology
, vol.67
, pp. 294-299
-
-
Tzai, T.S.1
Tsai, Y.S.2
Shiau, A.L.3
Wu, C.L.4
Shieh, G.S.5
Tsai, H.T.6
-
19
-
-
34247630071
-
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray
-
Higgins JP, Kaygusuz G, Wang L et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 2007; 31: 673-80.
-
(2007)
Am J Surg Pathol
, vol.31
, pp. 673-680
-
-
Higgins, J.P.1
Kaygusuz, G.2
Wang, L.3
-
20
-
-
3042566967
-
Growth-regulated expression and G0-specific turnover of the mRNA that encodes URH49, a mammalian DExH/D box protein that is highly related to the mRNA export protein UAP56
-
Pryor A, Tung L, Yang Z, Kapadia F, Chang TH, Johnson LF. Growth-regulated expression and G0-specific turnover of the mRNA that encodes URH49, a mammalian DExH/D box protein that is highly related to the mRNA export protein UAP56. Nucleic Acids Res 2004; 32: 1857-65.
-
(2004)
Nucleic Acids Res
, vol.32
, pp. 1857-1865
-
-
Pryor, A.1
Tung, L.2
Yang, Z.3
Kapadia, F.4
Chang, T.H.5
Johnson, L.F.6
-
21
-
-
33846660976
-
Intracellular characterization of DDX39, a novel growth-associated RNA helicase
-
Sugiura T, Sakurai K, Nagano Y. Intracellular characterization of DDX39, a novel growth-associated RNA helicase. Exp Cell Res 2007; 313: 782-90.
-
(2007)
Exp Cell Res
, vol.313
, pp. 782-790
-
-
Sugiura, T.1
Sakurai, K.2
Nagano, Y.3
-
22
-
-
14944360753
-
Over-expression of RNA helicases in cancer
-
Abdelhaleem M. Over-expression of RNA helicases in cancer. Anticancer Res 2004; 24: 3951-3.
-
(2004)
Anticancer Res
, vol.24
, pp. 3951-3953
-
-
Abdelhaleem, M.1
-
23
-
-
40949137131
-
DDX39, upregulated in lung squamous cell cancer, displays RNA helicase activities and promotes cancer cell growth
-
Sugiura T, Nagano Y, Noguchi Y. DDX39, upregulated in lung squamous cell cancer, displays RNA helicase activities and promotes cancer cell growth. Cancer Biol Ther 2007; 6: 957-64.
-
(2007)
Cancer Biol Ther
, vol.6
, pp. 957-964
-
-
Sugiura, T.1
Nagano, Y.2
Noguchi, Y.3
-
24
-
-
0029063684
-
Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer
-
Lipponen PK, Eskelinen MJ. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol 1995; 121: 303-8.
-
(1995)
J Cancer Res Clin Oncol
, vol.121
, pp. 303-308
-
-
Lipponen, P.K.1
Eskelinen, M.J.2
-
25
-
-
76549130383
-
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity
-
Kumar B, Koul S, Petersen J et al. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 2010; 70: 832-41.
-
(2010)
Cancer Res
, vol.70
, pp. 832-841
-
-
Kumar, B.1
Koul, S.2
Petersen, J.3
-
26
-
-
45849140589
-
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
-
Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008; 54: 303-14.
-
(2008)
Eur Urol
, vol.54
, pp. 303-314
-
-
Babjuk, M.1
Oosterlinck, W.2
Sylvester, R.3
Kaasinen, E.4
Bohle, A.5
Palou-Redorta, J.6
-
27
-
-
79955425871
-
Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines
-
Sakano S, Matsuyama H, Takai K et al. Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines. BJU Int 2011; 107: 1598-604.
-
(2011)
BJU Int
, vol.107
, pp. 1598-1604
-
-
Sakano, S.1
Matsuyama, H.2
Takai, K.3
|